Lizid 400 mg (Tablet)
Unit Price: ৳ 60.00 (2 x 10: ৳ 1,200.00)
Strip Price: ৳ 600.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Linezolid |
| Company | Radiant pharmaceuticals ltd |
| Also available as |
Indications
- Treatment of Nosocomial pneumonia
- Treatment of Community-acquired pneumonia
- Treatment of Complicated skin and skin structure infection
- Treatment of Uncomplicated skin and skin structure infections
- Treatment of Vancomycin-resistant Enterococcus faecium infections
Pharmacology
- Synthetic antibacterial agent
- Belongs to oxazolidinones class
- In vitro activity against Gram positive aerobic bacteria
- In vitro activity against Gram positive anaerobic bacteria
- In vitro activity against certain Gram negative bacteria
Dosage & Administration
- Oral route administration
- IV infusion administration
- Dosage varies based on infection type
- Dosage for pediatric patients
- Dosage for adults and adolescents
- Recommended duration of treatment
- No dose adjustment necessary between IV and oral administration
Interaction
- Reversible inhibitor of monoamine oxidase
- Potential interactions with adrenergic and serotonergic agents
- Enhancement of pressor response possible
- Avoid high tyramine content foods while taking
Contraindications
- Contraindicated in patients with hypersensitivity to Linezolid
- Contraindicated in patients taking MAO inhibitors
- Contraindicated in patients with uncontrolled hypertension
- Contraindicated in patients with specific medical conditions
Side Effects
- Most adverse events reported were mild to moderate
- Common side effects include diarrhea, headache, and nausea
- Other side effects include oral/vaginal moniliasis, hypertension, etc.
Pregnancy & Lactation
- Use during pregnancy if benefit justifies risk
- Consideration needed for breastfeeding mothers
- Monitor breastfed infant for adverse effects
Precautions & Warnings
- Monitor blood counts in patients on long-term treatment
- Ophthalmic evaluation recommended for visual impairment symptoms
- Not approved for catheter-related infections
- C. difficile-associated Diarrhea risk
- Monitoring required for potential blood pressure increases
Overdose Effects
- No reported cases of overdose
- Symptomatic and supportive care advised
- Approximately 30% of dose removed during haemodialysis
- No data for peritoneal dialysis or haemoperfusion
Therapeutic Class
- Belongs to Macrolides class
Reconstitution
- Shake bottle for oral suspension reconstitution
- Add boiled and cooled water to dry mixture
- Shake well after each addition
- Intravenous administration instructions for ready-to-use infusion bottles
Storage Conditions
- Store at room temperature away from light and moisture
- Keep away from children